Does the presence of ANCA in patients with ulcerative colitis necessarily imply renal involvement?

Nephrology Dialysis Transplantation

Volumn 11, Issue 12, 1996, Pages 2426-2429

  Rosa, M ^a   Esposito, C ^a   Caglioti, A ^a   Mazza, G ^a   Capria, M ^a   Comi, N ^a   Monteleone, G ^a   Sinico, R A ^b   Fuiano, G ^a,c  

^a Faculty of Medicine   (Italy)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

^c Facolta di Medicina   (Italy)

Author keywords

Alpha granules; IgA ANCA; IgG ANCA; Myeloperoxidase; Vasculitis

Indexed keywords

CREATININE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOFERRIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; KIDNEY DISEASE; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0030455133     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027209     Document Type: Article

References (38)

1. Falk RJ, Jennette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-1657
2. Van der Woude FJ, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: tool of diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425-429
3. Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibodies associated glomerulonephritis and vasculitis. Am J Pathol 1989; 135: 921-930
4. Hauschild S, Schmitt WH, Csernok E, Flesch BK, Rautmann A, Gross WL. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol 1993; 336: 245-251
5. Falk RJ, Terrel RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87: 4115-4119
6. Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 1990; 15: 517-529
7. Ewert BH, Jennette JC, Falk RJ. The pathogenic role of antineutrophil cytoplasmic autoantibodies. J Kidney Dis 1991; 18: 188-195
8. Savage COS, Winearls CG, Jones S, Marshall PD, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987; 1: 1389-1393
9. Nolle B, Specks U, Ludemann J, Rohrbach MS, Deremee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med 1989; 111: 28-40
10. Cohen Tervaert JW, Huitema MG, Henè RJ et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990; 336: 709-711
11. Duerr RH, Targan SR, Landers CJ et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100: 1385-1391
12. Pool MO, Ellerbroek PM, Ridwan BU et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 1993; 34: 46-50
13. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrheal disease. Gastroenterohgy 1991; 100: 1590-1596
14. Juby C, Johnston C, Davies P, Russel AS. Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome. Br J Reumatol 1992; 31: 185-188
15. Wagner J, Andrassy K, Ritz E. Is vasculitis in subacute bacterial endocarditis associated with ANCA? Lancet 1991; 337: 799-780
16. Klaassen RJL, Goldschmeding R, Dolman KM et al. Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol 1992; 87: 24-30
17. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91: 1-12
18. Miller RB. Urinalysis. In Massry SG, Glassock RJ, eds. Textbook of Nephrology, 2nd edn. William & Wilkins, Baltimore 1989; 1587-1609
19. Ferrario G, Meroni PL, Tincani A et al. Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immunol 1990; 79: 45-53
20. Rasmussen N, Sjolin C, Isakssson B, Bygren P, Wieslander J. An ELISA for detection of antineutrophil cytoplasm antibodies (ANCA). J Immunol Methods 1990; 127; 139-145
21. Hagen EC, Andrassy K, Csernok E et al. The value of indirect immunofluorescence and solid phase technique for ANCA detection. J Immunol Methods 1993; 159: 1-16
22. Weis Leid R, Van der Heijden I, Ballieux BEPB et al. Cleavage and inactivation of human CI-inhibitor by the human leukocyte proteinase, proteinase 3. Eur J Immunol 1993; 23, 2939-2944
23. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989; 97 [Suppl 6]: 12-13
24. Truelowe SC, Edwards FC. The course and prognosis of ulcerative colitis. I. Short-term prognosis. Gut 1964; 4: 299
25. Falk RJ. ANCA-associated renal diseases. Kidney Int 1990; 38: 998-1010
26. Savage COS, Cooke SP. The role of the endothelium in systemic vasculitis. J Autoimmun 1993; 6: 237-249
27. Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 1992; 41: 375-383
28. Glickmann RM. Inflammatory bowel disease. In: Harrison's. Principles of Internal Medicine. McGraw Hill 1991. 242: 1268-81
29. Ellerbroek PM, Ouderk Pool M, Ridwan BU et al. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol 1994; 47: 257-262
30. Deusch K, Oberstadt K, Schaedel W, Weber M, Classen M. p-ANCA as a diagnostic marker in ulcerative colitis. Adv Exp Med Biol 1993; 336: 527-531
31. Cambridge G, Rampton DS, Stevens TRJ, McCarthy DA, Kamm M, Laker B. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1992; 33: 668-674
32. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86: 202-210
33. Kain R Matsui K, Exner M et al. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the Iysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocites and a related membrane protein in glomerular endothelial cells. J Exp Med 1995; 585-597
34. Kallemberg CGM, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies (ANCA): new tools in the diagnosis and follow-up of necrotizing glomerulonephritis and vasculitis In: Andreucci VE, Fine LG eds. International Yearbook of Nephrology 1992; 313-336
35. Kallemberg CGM, Brower E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1-15
36. Savage COS, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Myeloperoxidase (MPO) binds to cultured umbilical vein endothelial cells (HUVEC) and is recognised by autoantibodies, P-ANCA, from patients with systemic vasculitis. J Am Soc Nephrol 1991; 2: 604
37. Mulder AHL, Horst G, Limburg PC, Kallenberg CGM. Activation of neutrophils by anti-neutrophil cytoplasmic antibody is FcR-dependent. Clin Exp Immunol 1993 [Suppl 1]: S16
38. Kobayashi K, Shibata T, Sugisaki T. Aggravation of rat Masugi nephritis by heterologous anti-rat myeloperoxidase antibody. Clin Exp Immunol 1993 [Suppl 1]. S20